World's Best Scientists 2026 revealed!
Hitomi Sezaki

Hitomi Sezaki

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Microbiology 56 3704 3398 147 135 274 11391

Hitomi Sezaki publications per year

The chart shows the history of publications by Hitomi Sezaki between 2003 and 2024, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Hitomi Sezaki published across 22 years, from 2003 to 2024, averaging 14.5 papers a year. Output peaked at 25 publications in 2007. 14 of the 320 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 2003 to 2024. Vertical axis: number of publications, 0 to 25. Peak 25 publications in 2007. 2003: 1 publication 2004: 12 publications 2005: 14 publications 2006: 16 publications 2007: 25 publications 2008: 20 publications 2009: 22 publications 2010: 18 publications 2011: 15 publications 2012: 20 publications 2013: 16 publications 2014: 14 publications 2015: 12 publications 2016: 9 publications 2017: 17 publications 2018: 12 publications 2019: 17 publications 2020: 17 publications 2021: 19 publications 2022: 10 publications 2023: 11 publications 2024: 3 publications
2003 2024

320 publications in total across all disciplines

View publications per year as a table
Hitomi Sezaki: publications per year, 2003 to 2024
Year Publications
2003 1
2004 12
2005 14
2006 16
2007 25
2008 20
2009 22
2010 18
2011 15
2012 20
2013 16
2014 14
2015 12
2016 9
2017 17
2018 12
2019 17
2020 17
2021 19
2022 10
2023 11
2024 3
Total 320
Download as CSV

Hitomi Sezaki publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Hitomi Sezaki sits on this spectrum.

No. of scientists
50 100 150 200 250
Bar chart with 64 bars. Horizontal axis: publications, 55–64 to 679+. Vertical axis: number of scientists, 0 to 288. Most scientists, 288, have 135–144 publications. The last bar groups every scientist with 679 publications or more. The highlighted bar, 265–274 publications, is where this scientist sits. 55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55–64 publications 679+

This scientist: 274 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

View publications distribution as a table
Number of Microbiology scientists by publication count, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
Publications Scientists This scientist
55–64 8
65–74 29
75–84 55
85–94 112
95–104 137
105–114 190
115–124 235
125–134 234
135–144 288
145–154 265
155–164 264
165–174 253
175–184 276
185–194 190
195–204 234
205–214 208
215–224 198
225–234 155
235–244 161
245–254 160
255–264 146
265–274 139 274
275–284 148
285–294 115
295–304 96
305–314 88
315–324 106
325–334 65
335–344 76
345–354 64
355–364 62
365–374 65
375–384 61
385–394 34
395–404 44
405–414 36
415–424 35
425–434 29
435–444 33
445–454 34
455–464 25
465–474 26
475–484 20
485–494 19
495–504 16
505–514 17
515–524 23
525–534 14
535–544 14
545–554 18
555–564 12
565–574 7
575–584 9
585–594 9
595–604 9
605–614 7
615–624 9
625–634 7
635–644 4
645–654 5
655–664 6
665–674 7
675–678 3
679+ 99
Download as CSV

Hitomi Sezaki D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Hitomi Sezaki sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 88 bars. Horizontal axis: D-Index, 40 to 127+. Vertical axis: number of scientists, 0 to 162. Most scientists, 162, have 58 D-Index. The last bar groups every scientist with 127 D-Index or more. The highlighted bar, 56 D-Index, is where this scientist sits. 40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 56 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

View D-Index distribution as a table
Number of Microbiology scientists by D-index, Research.com 2026 ranking edition. Based on 5,513 ranked scientists.
D-Index Scientists This scientist
40 30
41 86
42 90
43 117
44 122
45 123
46 108
47 110
48 106
49 109
50 129
51 111
52 116
53 127
54 134
55 134
56 112 56
57 136
58 162
59 151
60 139
61 123
62 126
63 144
64 109
65 103
66 124
67 112
68 103
69 131
70 94
71 93
72 96
73 92
74 80
75 66
76 87
77 60
78 73
79 59
80 57
81 55
82 47
83 77
84 50
85 45
86 42
87 41
88 32
89 38
90 35
91 34
92 27
93 26
94 33
95 22
96 37
97 22
98 21
99 22
100 30
101 16
102 20
103 17
104 19
105 16
106 19
107 18
108 14
109 10
110 9
111 7
112 11
113 6
114 15
115 10
116 12
117 7
118 10
119 10
120 11
121 2
122 7
123 12
124 5
125 9
126 6
127+ 95
Download as CSV

Overview

Hitomi Sezaki is affiliated with Toranomon Hospital in Japan and has contributed extensively to medical research, particularly in the field of hepatology. Their academic work spans a range of topics focused on liver diseases, cancer treatment, and liver-related diagnostic techniques.

The main fields of study for Sezaki include Medicine, with a strong focus on subfields such as Hepatology, Epidemiology, Oncology, Radiology, Nuclear Medicine and Imaging, and Endocrinology, Diabetes and Metabolism.

The primary research topics covered in Sezaki's work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis B Virus Studies
  • Hepatitis C Virus Research
  • Liver Disease and Transplantation
  • Pancreatic and Hepatic Oncology Research
  • MRI in Cancer Diagnosis

Sezaki has published in various scientific venues, with frequent contributions to the following journals:

  • Oncology
  • Hepatology Research
  • Internal Medicine
  • Clinical Journal of Gastroenterology
  • Kanzo

Among the recent papers authored are:

  • Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis, 2020, The Lancet. Gastroenterology & Hepatology
  • Lenvatinib-Transarterial Chemoembolization Sequential Therapy as an Effective Treatment at Progression during Lenvatinib Therapy for Advanced Hepatocellular Carcinoma, 2020, Liver Cancer
  • A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis, 2021, Med
  • SGLT2 Inhibitor Treatment Outcome in Nonalcoholic Fatty Liver Disease Complicated with Diabetes Mellitus: The Long-term Effects on Clinical Features and Liver Histopathology, 2020, Internal Medicine
  • Pretreatment Heterogeneous Enhancement Pattern of Hepatocellular Carcinoma May Be a Useful New Predictor of Early Response to Lenvatinib and Overall Prognosis, 2020, Liver Cancer

Sezaki's research collaborations include frequent co-authors such as Hiromitsu Kumada, Tetsuya Hosaka, Yusuke Kawamura, Norio Akuta, and Fumitaka Suzuki. These collaborative works contribute to the interdisciplinary approach spanning hepatology, oncology, and clinical medicine.

Best Publications

  • Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

    Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko

  • Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: Amino acid substitutions in the core region and low-density lipoprotein cholesterol levels

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

    Norio Akuta;Fumitaka Suzuki;Miharu Hirakawa;Yusuke Kawamura

  • Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

    Yasuji Arase;Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta

  • Large-scale long-term follow-up study of Japanese patients with non-alcoholic Fatty liver disease for the onset of hepatocellular carcinoma.

    Yusuke Kawamura;Yasuji Arase;Kenji Ikeda;Yuya Seko

  • Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C.

    Yasuji Arase;Mariko Kobayashi;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patients

    Atsushi Ono;Fumitaka Suzuki;Yusuke Kawamura;Hitomi Sezaki

  • Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

    Yasuji Arase;Kenji Ikeda;Fumitaka Suzuki;Yoshiyuki Suzuki

  • Viral elimination reduces incidence of malignant lymphoma in patients with hepatitis C

    Yusuke Kawamura;Kenji Ikeda;Yasuji Arase;Hiromi Yatsuji

  • Amino acid substitutions in the hepatitis C virus core region are the important predictor of hepatocarcinogenesis.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C

    Kazuaki Chayama;C. Nelson Hayes;Hiromi Abe;Daiki Miki

  • Sustained virologic response by direct antiviral agents reduces the incidence of hepatocellular carcinoma in patients with HCV infection.

    Masahiro Kobayashi;Fumitaka Suzuki;Shunichiro Fujiyama;Yusuke Kawamura

  • Prevalence of hepatitis C virus variants resistant to NS3 protease inhibitors or the NS5A inhibitor (BMS-790052) in hepatitis patients with genotype 1b

    Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta;Yoshiyuki Suzuki

  • Predictors of viral kinetics to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b.

    Norio Akuta;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

  • Predictive factors of virological non-response to interferon–ribavirin combination therapy for patients infected with hepatitis C virus of genotype1b and high viral load

    Norio Akuta;Fumitaka Suzuki;Hitomi Sezaki;Yoshiyuki Suzuki

  • Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up☆

    Hiromi Yatsuji;Fumitaka Suzuki;Hitomi Sezaki;Norio Akuta

  • Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir.

    Fumitaka Suzuki;Yoshiyuki Suzuki;Norio Akuta;Hitomi Sezaki

  • Effects of a sodium-glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: Preliminary prospective study based on serial liver biopsies.

    Norio Akuta;Chizuru Watanabe;Yusuke Kawamura;Yasuji Arase

  • Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non-alcoholic fatty liver disease complicated by diabetes mellitus

    Norio Akuta;Yusuke Kawamura;Chizuru Watanabe;Akihiro Nishimura

  • Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads.

    Hitomi Sezaki;Fumitaka Suzuki;Yusuke Kawamura;Hiromi Yatsuji

Frequent Co-Authors

Hiromitsu Kumada
Hiromitsu Kumada Fukuoka University
Tetsuya Hosaka
Tetsuya Hosaka Toranomon Hospital
Yoshiyuki Suzuki
Yoshiyuki Suzuki Fukushima Medical University
Masahiro Kobayashi
Masahiro Kobayashi Toranomon Hospital
Yasuji Arase
Yasuji Arase University of Yamanashi
Fumitaka Suzuki
Fumitaka Suzuki Toranomon Hospital
Kenji Ikeda
Kenji Ikeda University of California, San Francisco
Satoshi Saitoh
Satoshi Saitoh Toranomon Hospital
Mariko Kobayashi
Mariko Kobayashi Kaohsiung Medical University
Yuzo Miyakawa
Yuzo Miyakawa Miyakawa Memorial Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in microbiology opens doors to diverse career paths, many of which can be complemented by related online degrees. For individuals with unique circumstances, such as those seeking the best associate degrees for felons, online programs offer flexible options to build skills and re-enter the workforce effectively.

Healthcare is a prominent field linked to microbiology. For example, becoming a functional medicine nurse practitioner involves advanced knowledge of biology and patient care, making it a suitable transition for microbiology graduates interested in clinical roles. Similarly, the field of medical coding provides alternative career pathways. Earning certification as a certified professional coder (CPC) allows you to work in healthcare administration, combining detail orientation with healthcare knowledge.

Another growing sector is health information management. This career requires expertise in managing patient data and health records, often supported by backgrounds in science and technology. Understanding the health information management job description and salary can help you assess if this path aligns with your career goals.

Exploring these related degrees and career options can enhance your opportunities and provide valuable alternatives within the biomedical and healthcare industries.

Best Scientists Citing Hitomi Sezaki

Trending Scientists

Recently Published Articles